Revisiting the Environmental Impact of Inappropriate Clinical Laboratory Testing: A Comprehensive Overview of Sustainability, Economic, and Quality of Care Outcomes.


Journal

The journal of applied laboratory medicine
ISSN: 2576-9456
Titre abrégé: J Appl Lab Med
Pays: England
ID NLM: 101693884

Informations de publication

Date de publication:
03 Oct 2024
Historique:
received: 21 04 2024
accepted: 11 06 2024
medline: 3 10 2024
pubmed: 3 10 2024
entrez: 3 10 2024
Statut: aheadofprint

Résumé

The use of laboratory resources has seen a substantial increase in recent years, driven by automation and emerging technologies. However, inappropriate use of laboratory testing, encompassing both overuse and underuse, poses significant challenges. This review explores the complex interplay between patient safety, economic, and environmental factors-known as the "triple bottom line" or "3Ps" for people, profit, and planet-associated with inappropriate use of laboratory resources. The first part of the review outlines the impact of inappropriate laboratory testing on patient safety and economic outcomes. Then the review examines the available literature on the environmental impact of laboratory activities. Several practical solutions for mitigating the environmental impact of laboratories are discussed. Finally, this review emphasizes how decreasing unnecessary laboratory testing results in cost savings and environmental benefits, as evidenced by interventional studies, without compromising patient safety. The implementation of sustainable practices in laboratories can create a virtuous circle in which reduced testing enhances cost-efficiency, reduces the environmental footprint, and ensures patient safety, thereby benefiting the 3Ps. This review highlights the critical need for appropriate laboratory resource utilization in achieving sustainability in healthcare.

Sections du résumé

BACKGROUND BACKGROUND
The use of laboratory resources has seen a substantial increase in recent years, driven by automation and emerging technologies. However, inappropriate use of laboratory testing, encompassing both overuse and underuse, poses significant challenges.
CONTENT BACKGROUND
This review explores the complex interplay between patient safety, economic, and environmental factors-known as the "triple bottom line" or "3Ps" for people, profit, and planet-associated with inappropriate use of laboratory resources. The first part of the review outlines the impact of inappropriate laboratory testing on patient safety and economic outcomes. Then the review examines the available literature on the environmental impact of laboratory activities. Several practical solutions for mitigating the environmental impact of laboratories are discussed. Finally, this review emphasizes how decreasing unnecessary laboratory testing results in cost savings and environmental benefits, as evidenced by interventional studies, without compromising patient safety.
SUMMARY CONCLUSIONS
The implementation of sustainable practices in laboratories can create a virtuous circle in which reduced testing enhances cost-efficiency, reduces the environmental footprint, and ensures patient safety, thereby benefiting the 3Ps. This review highlights the critical need for appropriate laboratory resource utilization in achieving sustainability in healthcare.

Identifiants

pubmed: 39360969
pii: 7808806
doi: 10.1093/jalm/jfae087
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Association for Diagnostics & Laboratory Medicine 2024. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.

Auteurs

Luigi Devis (L)

Department of Laboratory Medicine, Biochemistry, CHU UCL Namur, UCLouvain, Yvoir, Belgium.

Mélanie Closset (M)

Department of Laboratory Medicine, Biochemistry, CHU UCL Namur, UCLouvain, Yvoir, Belgium.

Jonathan Degosserie (J)

Department of Laboratory Medicine, Molecular Biology, CHU UCL Namur, UCLouvain, Yvoir, Belgium.
Namur Research Institute for Life Sciences, Université de Namur, CHU UCL Namur, Namur, Belgium.

Sarah Lessire (S)

Namur Research Institute for Life Sciences, Université de Namur, CHU UCL Namur, Namur, Belgium.
Blood Transfusion Center, CHU UCL Namur, UCLouvain, Yvoir, Belgium.
Namur Thrombosis and Hemostasis Center, CHU UCL Namur, UCLouvain, Yvoir, Belgium.
Institute of Experimental and Clinical Research, UCLouvain, Brussels, Belgium.

Pauline Modrie (P)

Sustainability Consultant, CHU UCL Namur, UCLouvain, Yvoir, Belgium.
Institute of Health and Society, UCLouvain, Brussels, Belgium.

Damien Gruson (D)

Department of Clinical Biochemistry, Cliniques Universitaires St-Luc, UCLouvain, Brussels, Belgium.

Emmanuel J Favaloro (EJ)

Department of Haematology, Centres for Thrombosis and Haemostasis, Institute of Clinical Pathology and Medical Research, NSW Health Pathology, Westmead Hospital, Westmead, New South Wales, Australia.
School of Dentistry and Medical Sciences, Faculty of Science and Health, Charles Sturt University, Wagga Wagga, New South Wales, Australia.
School of Medical Sciences, Faculty of Medicine and Health, University of Sydney, Westmead Hospital, Westmead, New South Wales, Australia.

Giuseppe Lippi (G)

Section of Clinical Biochemistry, University of Verona, Verona, Italy.

François Mullier (F)

Namur Research Institute for Life Sciences, Université de Namur, CHU UCL Namur, Namur, Belgium.
Namur Thrombosis and Hemostasis Center, CHU UCL Namur, UCLouvain, Yvoir, Belgium.
Institute of Experimental and Clinical Research, UCLouvain, Brussels, Belgium.
Department of Laboratory Medicine, Hematology, CHU UCL Namur, UCLouvain, Belgium.

Emilie Catry (E)

Department of Laboratory Medicine, Biochemistry, CHU UCL Namur, UCLouvain, Yvoir, Belgium.

Classifications MeSH